J Korean Soc Microbiol.
2000 Feb;35(1):1-8.
Antiviral activity of ascorbic acid against herpes simplex virus
- Affiliations
-
- 1Department of Microbiology, College of Medicine, Kyung
Hee University, 1 Hoegi-dong, Dongdaemun-gu, Seoul, 130-701, South Korea.
Abstract
-
In order to explore the potential of ascorbic acid
supplementation for the prevention and treatment of herpes simplex viral
diseases, plaque reduction assays were performed. Ascorbic acid as well
as copper chloride/ferric chloride were added to wells containing Vero
cells infected with herpes simplex virus type 1 (HSV-1), and the
infectivity of HSV-1 was determined. Since copper and iron are major
transition metals in human plasma, near the normal human plasma
concentrations of them were used for experiments. When Cu(II) and Fe(III)
were applied, there were no significant differences between virus control
and Cu(II)/Fe(III)-treated groups. But, when appropriate concentrations
of ascorbic acid were added to wells, meaningful differences between
control and ascorbate-treated groups were found. In the presence of
Cu(II)/Fe(III) at 5.8/3.7 muM, 72-h treatment with ascorbate at 50 muM
reduced HSV-1 infections to 10.77%+/-4.25% (P<0.001) and 500 muM did to
3.06%+/-1.62% (P<0.001). Moreover, the cytotoxicities for Vero cells at
those concentrations were insignificant (P > 0.05). Current recommended
dietary allowance (RDA) of ascorbic acid is 60 mg/day, and the oral
intake of 60 mg/day of ascorbic acid yields plasma ascorbic acid at 45 to
58 muM in a healthy adult man. Therefore, the results of this study
suggest that the maintenance of appropriate level (more than 50 muM) of
ascorbic acid in human plasma by appropriate amount (more than the RDA)
of ascorbic acid supplementation may be helpful for the prevention and
treatment of diseases caused by HSV-1 in an adult man. In addition, this
study also suggests that ascorbic acid may be useful for the prophylaxis
of fatal HSV-1 infections in neonates and the prevention of HSV-1
reactivation in immunocompromised hosts.